Study on Serum Zinc and Selenium Levels in Epileptic Patients
- Conditions
- Generalized Epileptic
- Registration Number
- NCT01764516
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
This study was carried out with the purpose of evaluating zinc and selenium levels in serum of epileptic patients and compare with normal individuals.
- Detailed Description
Forty patients aged 18 to 50 years visiting Vali-Asr hospital in Arak, I.R. Iran, who were diagnosed with generalized form of epilepsy by a neurologist for the first time were recruited as cases. The control group (n=40) was selected from healthy individuals, in whom no disease was diagnosed until this study, and were matched to the case group by age, sex, and economical status.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
New generalized and single epileptic cases patients who accept and sign the approval form of ethical committee non smoker, no trauma, no use of selenium supplement, no use of zinc supplement, no use of vitamin A supplement, no use of vitamin D supplement, no Weight loss, no Diarrhea, no addiction, no alcohol consumption, no use of certain medications,
presence of above criteria as well as, generalized and single epileptic cases under treatment
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Study on Serum Zinc and Selenium Levels in Epileptic Patients 5 months decrement in serum zinc and selenium level
- Secondary Outcome Measures
Name Time Method Comparison between the selenium levels by gender in two groups 5 months
Trial Locations
- Locations (1)
Vali-Asr Hospital
🇮🇷Arak, Central province, Iran, Islamic Republic of